Christina Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christina Peng has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Ray Truant
McMaster University
6 shared publications - Carlos Barba Bazan
Department of Biochemistry and Biomedical Sciences, McMaster University
2 shared publications - Kaitlyn Neuman
Department of Biochemistry and Biomedical Sciences, McMaster University
2 shared publications - Lauren Hong
Department of Biomedical Engineering, Duke University, Durham, USA
2 shared publications - Lin Zhao
Department of Biomedical Engineering, Duke University, Durham, NC, USA
2 shared publications - Pranam Chatterjee
University of Pennsylvania
2 shared publications
Latest Publications
- Open Access
Direct Measure of DNA Damage in Huntington Disease Reveals Elevated Oxidative Genotoxic Stress and Dysfunctional DNA Repair
DNA damage repair (DDR) pathway proteins are genetic modifiers of Huntington disease (HD) age of onset and severity. Deficient DDR in HD at the first steps of poly ADP-ribosylation makes DNA damage quantification by traditional downstream DNA damage response markers inaccurate. Repair Assisted Damage Detection (RADD) allows for an accurate direct assessment of oxidative DNA damage, a DDR pathway in which huntingtin protein directly participates. Using RADD, we show that human HD-derived cells have elevated oxidative DNA damage and assess the effect of relevant HD therapeutic targets in rescuing this phenotype. Using huntingtin protein level lowering, we define a dysfunctional role of mutant huntingtin in oxidative DDR. We show that ataxia-telangiectasia mutated (ATM) signaling is deficient and that ATM inhibition rescues elevated oxidative DNA damage in HD cells. In contrast, we show that N6-furfuryladenine (N6FFA) treatment, to increase huntingtin phosphorylation within the amino terminal N17 domain (p-N17), is not effective at restoring HD DDR but reveals dysfunctional N6FFA mediated DDR signaling. We propose a model in which elevated DNA damage arises from both aberrant mutant huntingtin involvement in oxidative DDR and the impairment of oxidative DDR pathways, such as ATM kinase activity, N6FFA processing, and poly ADP-ribose signaling in HD. This highlights the importance of using direct measures of DNA damage such as RADD, rather than measures of a DNA damage response pathway.
Open AccessDirect Measure of DNA Damage in Huntington Disease Reveals Elevated Oxidative Genotoxic Stress and Dysfunctional DNA Repair
DNA damage repair (DDR) pathway proteins are genetic modifiers of Huntington disease (HD) age of onset and severity. Deficient DDR in HD at the first steps of poly ADP-ribosylation makes DNA damage quantification by traditional downstream DNA damage response markers inaccurate. Repair Assisted Damage Detection (RADD) allows for an accurate direct assessment of oxidative DNA damage, a DDR pathway in which huntingtin protein directly participates. Using RADD, we show that human HD-derived cells have elevated oxidative DNA damage and assess the effect of relevant HD therapeutic targets in rescuing this phenotype. Using huntingtin protein level lowering, we define a dysfunctional role of mutant huntingtin in oxidative DDR. We show that ataxia-telangiectasia mutated (ATM) signaling is deficient and that ATM inhibition rescues elevated oxidative DNA damage in HD cells. In contrast, we show that N6-furfuryladenine (N6FFA) treatment, to increase huntingtin phosphorylation within the amino terminal N17 domain (p-N17), is not effective at restoring HD DDR but reveals dysfunctional N6FFA mediated DDR signaling. We propose a model in which elevated DNA damage arises from both aberrant mutant huntingtin involvement in oxidative DDR and the impairment of oxidative DDR pathways, such as ATM kinase activity, N6FFA processing, and poly ADP-ribose signaling in HD. This highlights the importance of using direct measures of DNA damage such as RADD, rather than measures of a DNA damage response pathway.
- Open Access
- 4 September 2025
- Published by SAGE Publications in Journal of Huntington's Disease
- Vol. 14 (4) , 293-303
Tipping the PARylation scale: Dysregulation of PAR signaling in Huntington and neurodegenerative diseases
Poly(ADP-ribosyl)ation (PARylation), a crucial post-translational modification, is catalyzed by ADP-ribosyltransferases (ARTs) and has significant implications in various cellular processes, including DNA damage response, cell signaling, and immune processes. Aberrant PAR signaling is implicated in numerous neurodegenerative diseases, including Alzheimer, Parkinson, amyotrophic lateral sclerosis, and cerebellar ataxia, where increased PAR levels and PARP1 activity are commonly observed. However, Huntington disease exhibits a unique characteristic: reduced PAR levels and impaired PARP1 activity even in prodromal phase. This finding challenges the prevailing understanding of PAR's role in neurodegeneration and suggests that dysregulation of PAR signaling, whether through overactivation or suppression, can lead to neuronal dysfunction. Herein, we discuss how this balance may impact neurodegenerative diseases, and possible connections between PAR signaling and emerging modifiers of disease onset identified by HD genome-wide association studies (GWAS).
- 4 September 2025
- Published by SAGE Publications in Journal of Huntington's Disease
- Vol. 14 (4) , 293-303
Open AccessTipping the PARylation scale: Dysregulation of PAR signaling in Huntington and neurodegenerative diseases
Poly(ADP-ribosyl)ation (PARylation), a crucial post-translational modification, is catalyzed by ADP-ribosyltransferases (ARTs) and has significant implications in various cellular processes, including DNA damage response, cell signaling, and immune processes. Aberrant PAR signaling is implicated in numerous neurodegenerative diseases, including Alzheimer, Parkinson, amyotrophic lateral sclerosis, and cerebellar ataxia, where increased PAR levels and PARP1 activity are commonly observed. However, Huntington disease exhibits a unique characteristic: reduced PAR levels and impaired PARP1 activity even in prodromal phase. This finding challenges the prevailing understanding of PAR's role in neurodegeneration and suggests that dysregulation of PAR signaling, whether through overactivation or suppression, can lead to neuronal dysfunction. Herein, we discuss how this balance may impact neurodegenerative diseases, and possible connections between PAR signaling and emerging modifiers of disease onset identified by HD genome-wide association studies (GWAS).
- Top Cited PapersOpen Access
- 13 August 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (6) , 1002-1010
Target sequence-conditioned design of peptide binders using masked language modeling
The computational design of protein-based binders presents unique opportunities to access 'undruggable' targets, but effective binder design often relies on stable three-dimensional structures or structure-influenced latent spaces. Here we introduce PepMLM, a target sequence-conditioned designer of de novo linear peptide binders. Using a masking strategy that positions cognate peptide sequences at the C terminus of target protein sequences, PepMLM finetunes the ESM-2 protein language model to fully reconstruct the binder region, achieving low perplexities matching or improving upon validated peptide-protein sequence pairs. After successful in silico benchmarking with AlphaFold-based docking, we experimentally validate the efficacy of PepMLM through both binding and degradation assays. PepMLM-derived peptides demonstrate sequence-specific binding to cancer and reproductive targets, including NCAM1 and AMHR2, and enable targeted degradation of proteins across diverse disease contexts, from Huntington's disease to live viral infections. Altogether, PepMLM enables the design of candidate binders to any target protein, without requiring structural input, facilitating broad applications in therapeutic development.
- 13 August 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (6) , 1002-1010
Top Cited PapersOpen AccessTarget sequence-conditioned design of peptide binders using masked language modeling
The computational design of protein-based binders presents unique opportunities to access 'undruggable' targets, but effective binder design often relies on stable three-dimensional structures or structure-influenced latent spaces. Here we introduce PepMLM, a target sequence-conditioned designer of de novo linear peptide binders. Using a masking strategy that positions cognate peptide sequences at the C terminus of target protein sequences, PepMLM finetunes the ESM-2 protein language model to fully reconstruct the binder region, achieving low perplexities matching or improving upon validated peptide-protein sequence pairs. After successful in silico benchmarking with AlphaFold-based docking, we experimentally validate the efficacy of PepMLM through both binding and degradation assays. PepMLM-derived peptides demonstrate sequence-specific binding to cancer and reproductive targets, including NCAM1 and AMHR2, and enable targeted degradation of proteins across diverse disease contexts, from Huntington's disease to live viral infections. Altogether, PepMLM enables the design of candidate binders to any target protein, without requiring structural input, facilitating broad applications in therapeutic development.
- Open Access
High Content System for Quantifying Mitochondrial Morphology in Patient-Derived Human Cells
Mitochondrial function is critical for cellular health, with dysfunction contributing to human diseases. Structural changes in mitochondria, such as size and shape, reflect alterations in bioenergetics, fission-fusion dynamics, and metabolic homeostasis. Existing morphological quantification is outdated, can be biased, technologically limited, or overly complex. This study presents a high content system for quantifying morphology using open-access resources and widely available equipment. Fibroblasts were stained with PKmito TM Dye Deep Red, imaged via automated confocal microscopy, and analyzed with CellProfiler™ and KNIME ® . We tested different imaging conditions and found live-cell confocal imaging at 60x magnification provided the most precise measurements. Using this system, we found that human Huntington Disease fibroblast mitochondria were significantly smaller and more circular, suggesting increased fission. To confirm our results, we employed other mitochondrial assays and found elevated expression of the fission protein Drp1, reduced respiration, impaired iron uptake, and increased membrane potential. This system offers a robust, unbiased high content approach to studying mitochondrial morphology in disease.
Open AccessHigh Content System for Quantifying Mitochondrial Morphology in Patient-Derived Human Cells
Mitochondrial function is critical for cellular health, with dysfunction contributing to human diseases. Structural changes in mitochondria, such as size and shape, reflect alterations in bioenergetics, fission-fusion dynamics, and metabolic homeostasis. Existing morphological quantification is outdated, can be biased, technologically limited, or overly complex. This study presents a high content system for quantifying morphology using open-access resources and widely available equipment. Fibroblasts were stained with PKmito TM Dye Deep Red, imaged via automated confocal microscopy, and analyzed with CellProfiler™ and KNIME ® . We tested different imaging conditions and found live-cell confocal imaging at 60x magnification provided the most precise measurements. Using this system, we found that human Huntington Disease fibroblast mitochondria were significantly smaller and more circular, suggesting increased fission. To confirm our results, we employed other mitochondrial assays and found elevated expression of the fission protein Drp1, reduced respiration, impaired iron uptake, and increased membrane potential. This system offers a robust, unbiased high content approach to studying mitochondrial morphology in disease.
- Open Access
- 4 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-8
PAM-flexible genome editing with an engineered chimeric Cas9
CRISPR enzymes require a defined protospacer adjacent motif (PAM) flanking a guide RNA-programmed target site, limiting their sequence accessibility for robust genome editing applications. In this study, we recombine the PAM-interacting domain of SpRY, a broad-targeting Cas9 possessing an NRN > NYN (R = A or G, Y = C or T) PAM preference, with the N-terminus of Sc + +, a Cas9 with simultaneously broad, efficient, and accurate NNG editing capabilities, to generate a chimeric enzyme with highly flexible PAM preference: SpRYc. We demonstrate that SpRYc leverages properties of both enzymes to specifically edit diverse PAMs and disease-related loci for potential therapeutic applications. In total, the approaches to generate SpRYc, coupled with its robust flexibility, highlight the power of integrative protein design for Cas9 engineering and motivate downstream editing applications that require precise genomic positioning.
- 4 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-8
Open AccessPAM-flexible genome editing with an engineered chimeric Cas9
CRISPR enzymes require a defined protospacer adjacent motif (PAM) flanking a guide RNA-programmed target site, limiting their sequence accessibility for robust genome editing applications. In this study, we recombine the PAM-interacting domain of SpRY, a broad-targeting Cas9 possessing an NRN > NYN (R = A or G, Y = C or T) PAM preference, with the N-terminus of Sc + +, a Cas9 with simultaneously broad, efficient, and accurate NNG editing capabilities, to generate a chimeric enzyme with highly flexible PAM preference: SpRYc. We demonstrate that SpRYc leverages properties of both enzymes to specifically edit diverse PAMs and disease-related loci for potential therapeutic applications. In total, the approaches to generate SpRYc, coupled with its robust flexibility, highlight the power of integrative protein design for Cas9 engineering and motivate downstream editing applications that require precise genomic positioning.
- Open Access
- 3 June 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (6) , e0269345
Mod3D: A low-cost, flexible modular system of live-cell microscopy chambers and holders
Live-cell microscopy imaging typically involves the use of high-quality glass-bottom chambers that allow cell culture, gaseous buffer exchange and optical properties suitable for microscopy applications. However, commercial sources of these chambers can add significant annual costs to cell biology laboratories. Consumer products in three-dimensional printing technology, for both Filament Deposition Modeling (FDM) and Masked Stereo Lithography (MSLA), have resulted in more biomedical research labs adopting the use of these devices for prototyping and manufacturing of lab plastic-based items, but rarely consumables. Here we describe a modular, live-cell chamber with multiple design options that can be mixed per experiment. Single reusable carriers and the use of biodegradable plastics, in a hybrid of FDM and MSLA manufacturing methods, reduce plastic waste. The system is easy to adapt to bespoke designs, with concept-to-prototype in a single day, offers significant cost savings to the users over commercial sources, and no loss in dimensional quality or reliability.
- 3 June 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (6) , e0269345
Open AccessMod3D: A low-cost, flexible modular system of live-cell microscopy chambers and holders
Live-cell microscopy imaging typically involves the use of high-quality glass-bottom chambers that allow cell culture, gaseous buffer exchange and optical properties suitable for microscopy applications. However, commercial sources of these chambers can add significant annual costs to cell biology laboratories. Consumer products in three-dimensional printing technology, for both Filament Deposition Modeling (FDM) and Masked Stereo Lithography (MSLA), have resulted in more biomedical research labs adopting the use of these devices for prototyping and manufacturing of lab plastic-based items, but rarely consumables. Here we describe a modular, live-cell chamber with multiple design options that can be mixed per experiment. Single reusable carriers and the use of biodegradable plastics, in a hybrid of FDM and MSLA manufacturing methods, reduce plastic waste. The system is easy to adapt to bespoke designs, with concept-to-prototype in a single day, offers significant cost savings to the users over commercial sources, and no loss in dimensional quality or reliability.
- Open Access
Mod3D: A Low-Cost, Flexible Modular System of Live-Cell Microscopy Chambers and Holders
Live-cell microscopy imaging typically involves the use of high-quality glass-bottom chambers that allow cell culture, gaseous buffer exchange and optical properties suitable for microscopy applications. However, commercial sources of these chambers can add significant annual costs to cell biology laboratories. Consumer products in three-dimensional printing technology, for both Filament Deposition Modeling (FDM) and Masked Stereo Lithography (MSLA), have resulted in more biomedical research labs adopting the use of these devices for prototyping and manufacturing of lab plastic-based items, but rarely consumables. Here we describe a modular, live-cell chamber with multiple design options that can be mixed per experiment. Single reusable carriers and the use of biodegradable plastics, in a hybrid of FDM and MSLA manufacturing methods, reduce plastic waste. The system is easy to adapt to bespoke designs, with concept-to-prototype in a single day, offers significant cost savings to the users over commercial sources, and no loss in dimensional quality or reliability.
Open AccessMod3D: A Low-Cost, Flexible Modular System of Live-Cell Microscopy Chambers and Holders
Live-cell microscopy imaging typically involves the use of high-quality glass-bottom chambers that allow cell culture, gaseous buffer exchange and optical properties suitable for microscopy applications. However, commercial sources of these chambers can add significant annual costs to cell biology laboratories. Consumer products in three-dimensional printing technology, for both Filament Deposition Modeling (FDM) and Masked Stereo Lithography (MSLA), have resulted in more biomedical research labs adopting the use of these devices for prototyping and manufacturing of lab plastic-based items, but rarely consumables. Here we describe a modular, live-cell chamber with multiple design options that can be mixed per experiment. Single reusable carriers and the use of biodegradable plastics, in a hybrid of FDM and MSLA manufacturing methods, reduce plastic waste. The system is easy to adapt to bespoke designs, with concept-to-prototype in a single day, offers significant cost savings to the users over commercial sources, and no loss in dimensional quality or reliability.